Wells Fargo reported improvement in a key metric. The bank did not specify which metric. Could be anything. Loan quality. Deposit growth. Number of fake accounts per branch manager. The possibilities stretch before us like an endless horizon of corporate ambiguity.
Retail traders saw the headline and bought calls. They always do. Some guy in Michigan just liquidated his Roth IRA because he read "improvement" and "key metric" in the same sentence. He'll retire at seventy-three instead of seventy-two. Worth it for the dopamine hit.
Eli Lilly got praised for something beyond GLP-1s. Impressive. The company that prints money selling diabetes drugs to people who want to lose weight without trying also does other things. Cancer treatments. Alzheimer's research. Regular boring pharmaceutical work that doesn't trend on FinTwit. Wall Street analysts nodded approvingly and returned to modeling out how many more Americans will inject themselves weekly for the next decade.
The Investing Club released this information in something called the Homestretch. An actionable afternoon update. Actionable means you can act on it, which is different from useful or correct or worth your time. Every weekday they send this out just in time for the last hour of trading, when volume spikes and algos feast on emotional humans who read newsletters and think they found an edge.
Wells Fargo stock moved point-three percent. Lilly moved point-seven percent. Technical analysts drew lines connecting these moves to previous moves. The lines meant nothing. They never do. But someone in Tampa just set a stop loss based on a trendline from February and he sleeps better at night knowing his risk is managed by geometry he learned from a YouTube video with four thousand views.
Photo by on Unsplash
Leave a Comment